RYBREVANT® + LAZCLUZE are targeted treatments that work together to fight cancer without needing chemotherapy.

RYBREVANT® is a targeted antibody* that works against EGFR mutations. LAZCLUZE is an EGFR-targeted TKI (tyrosine kinase inhibitor). RYBREVANT® + LAZCLUZE work against cancer in different ways:

RYBREVANT® helps stop the activity cancer cells use to grow and spread from outside the cancer cell.

RYBREVANT® also works with your immune system to help destroy the cancer. ​​

LAZCLUZE helps stop the activity cancer cells use to grow and spread from inside the cancer cell.​

*Antibodies are protective proteins that help detect harmful substances and diseases such as cancers. They are made naturally by your immune system and can also be man made. Man-made antibodies used to treat cancer have a specific target on a cancer cell that they aim to find, attach to, and attack. RYBREVANT® is a man-made antibody.

Side effects

There are side effects that you may experience during treatment with RYBREVANT®.

Doctor discussing possible side effects with RYBREVANT® patientDoctor discussing possible side effects with RYBREVANT® patient

Savings & Support

Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.

Rybrevant® with meRybrevant® with me